# Inebilizumab (Genetical Recombination) I.V. Infusion 100mg (ユプリズナ点滴静注１００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399429A1026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399429A1026
- **Product name (Japanese):** ユプリズナ点滴静注１００ｍｇ
- **English title:** Inebilizumab (Genetical Recombination) I.V. Infusion 100mg
- **Active ingredient:** イネビリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Inebilizumab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ１０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** Tanabe Pharma (田辺ファーマ)
- **NHI price (reference only):** JPY 3495304 per １００ｍｇ１０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399429A1026
- **JSON:** https://www.nifujipharma.com/api/drugs/6399429A1026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Inebilizumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20100mg%20(%E3%83%A6%E3%83%97%E3%83%AA%E3%82%BA%E3%83%8A%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%206399429A1026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.